EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
180 hedge funds and large institutions have $756M invested in Eagle Pharmaceuticals, Inc. in 2019 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 67 increasing their positions, 55 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
180
Holders Change
-2
Holders Change %
-1.1%
% of All Funds
3.92%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
19
Increased
67
Reduced
55
Closed
18
Calls
$7.99M
Puts
$10.6M
Net Calls
-$2.62M
Net Calls Change
+$1.64M
Top Buyers
| 1 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$14.2M |
| 2 |
LSV Asset Management
Chicago,
Illinois
|
+$8.59M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$7.51M |
| 4 |
Man Group
London,
United Kingdom
|
+$6.73M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$6.48M |
Top Sellers
| 1 |
JAM
JW Asset Management
Miami Beach,
Florida
|
-$21.5M |
| 2 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$14.7M |
| 3 |
Millennium Management
New York
|
-$10.1M |
| 4 |
HEC
Hudson Executive Capital
New York
|
-$8.87M |
| 5 |
Two Sigma Investments
New York
|
-$4.9M |
